Samuel Peprah

Samuel Peprah is an experienced professional in market access strategy and corporate strategy, currently serving as Director of Market Access Strategy at Pfizer since August 2021 and previously as Director of Corporate Strategy at Anthem, Inc. from July 2018 to June 2021. In addition to these roles, Samuel serves as an investor for Revert Technologies, Inc. and Renmo, Inc., and has been a Startup Business Advisor for Bridge for Billions since February 2020. Samuel's prior experience includes positions as an Investment Banking Summer Associate at William Blair and a Summer Fellow at Education Pioneers, along with research management at Social Solutions and consulting at Booz Allen Hamilton. Samuel holds an MBA from the Yale School of Management and a BA in Political Science from Brown University.